Πέμπτη 10 Μαΐου 2018

FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer

FDA has approved the combination of two immunotherapy drugs, nivolumab (Opdivo) and ipilimumab (Yervoy), as an initial treatment for some patients with advanced kidney cancer. Learn how this approval will affect patient care.



https://ift.tt/2KPIxXG

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου